BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16197719)

  • 1. Biology of osteogenic sarcoma.
    Wang LL
    Cancer J; 2005; 11(4):294-305. PubMed ID: 16197719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteosarcoma development and stem cell differentiation.
    Tang N; Song WX; Luo J; Haydon RC; He TC
    Clin Orthop Relat Res; 2008 Sep; 466(9):2114-30. PubMed ID: 18563507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance.
    Asnafi AA; Behzad MM; Ghanavat M; Shahjahani M; Saki N
    Exp Mol Pathol; 2019 Feb; 106():63-77. PubMed ID: 30528563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
    Gorlick R; Anderson P; Andrulis I; Arndt C; Beardsley GP; Bernstein M; Bridge J; Cheung NK; Dome JS; Ebb D; Gardner T; Gebhardt M; Grier H; Hansen M; Healey J; Helman L; Hock J; Houghton J; Houghton P; Huvos A; Khanna C; Kieran M; Kleinerman E; Ladanyi M; Lau C; Malkin D; Marina N; Meltzer P; Meyers P; Schofield D; Schwartz C; Smith MA; Toretsky J; Tsokos M; Wexler L; Wigginton J; Withrow S; Schoenfeldt M; Anderson B
    Clin Cancer Res; 2003 Nov; 9(15):5442-53. PubMed ID: 14654523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of osteosarcoma.
    Kansara M; Thomas DM
    DNA Cell Biol; 2007 Jan; 26(1):1-18. PubMed ID: 17263592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma.
    Benassi MS; Molendini L; Gamberi G; Magagnoli G; Ragazzini P; Gobbi GA; Sangiorgi L; Pazzaglia L; Asp J; Brantsing C; Picci P
    Cancer; 2001 Dec; 92(12):3062-7. PubMed ID: 11753985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Malignant Bone Tumors: A Review and Update on Current Challenges, and Emerging Drug Targets.
    Jackson TM; Bittman M; Granowetter L
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):213-228. PubMed ID: 27265835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
    Fenger JM; London CA; Kisseberth WC
    ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress on the livin gene and osteosarcomas.
    Li CJ; Cong Y; Liu XZ; Zhou X; Shi X; Wu SJ; Zhou GX; Lu M
    Asian Pac J Cancer Prev; 2014; 15(20):8577-9. PubMed ID: 25374170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECQ DNA helicases and osteosarcoma.
    Lu L; Jin W; Liu H; Wang LL
    Adv Exp Med Biol; 2014; 804():129-45. PubMed ID: 24924172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
    Lamoureux F; Trichet V; Chipoy C; Blanchard F; Gouin F; Redini F
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):169-81. PubMed ID: 17288528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response.
    Trujillo-Paolillo A; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia Filho RJ; de Oliveira R; de Toledo SRC
    Oncotarget; 2017 Jun; 8(24):38530-38540. PubMed ID: 28404946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
    Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
    Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future directions in the treatment of osteosarcoma.
    Bishop MW; Janeway KA; Gorlick R
    Curr Opin Pediatr; 2016 Feb; 28(1):26-33. PubMed ID: 26626558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions.
    Lussier DM; O'Neill L; Nieves LM; McAfee MS; Holechek SA; Collins AW; Dickman P; Jacobsen J; Hingorani P; Blattman JN
    J Immunother; 2015 Apr; 38(3):96-106. PubMed ID: 25751499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
    Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
    Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An analysis of genetic transmission in a father and son with osteosarcoma].
    Tokatli F; Alas RC; Altaner S; Pala F; Uygun K; Uzal C; Yalniz E
    Acta Orthop Traumatol Turc; 2006; 40(5):407-10. PubMed ID: 17220652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.